This is in addition to over $960,000 previously awarded to DMC by NSF through the SBIR Phase I and II programs. The additional funding will support the ongoing commercialization efforts of DMC’s Dynamic Metabolic Control technology platform and will help accelerate the company’s commercialization efforts.
DMC is scaling up to be a multi-product biobased chemical company. The first product family to come to market in 2020 will be specialty amino acids for food and feed. Pipeline product families include a variety of compounds with market applications in nutrition, personal care, flavor and fragrance, and fine chemicals.
This articles was originally posted at: https://www.biofuelsdigest.com/bdigest/2019/12/02/dmc-granted-additional-500000-nsf-small-business-innovation-research-grant/ on